HZ87ZZZMedication Management for Substance Abuse Treatment, Bupropion
- Billable / Specific Code
HZ87ZZZ is a billable ICD-10-PCS procedure code for Medication Management for Substance Abuse Treatment, Bupropion. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Medication Management involves monitoring and adjusting the use of replacement medications for the treatment of addiction.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | H | Substance Abuse Treatment |
| 2 | Body System | Z | Substance Abuse Treatment |
| 3 | Type | 8 | Medication Management |
| 4 | Qualifier | 7 | Bupropion |
| 5 | Qualifier | Z | None |
| 6 | Qualifier | Z | None |
| 7 | Qualifier | Z | None |
Convert to ICD-9-PCS
Closest ICD-9-PCS equivalents for HZ87ZZZ under the General Equivalence Mappings.
Similar Procedure Codes
Questions About HZ87ZZZ
Is HZ87ZZZ a billable code?
Yes. HZ87ZZZ is a complete seven-character ICD-10-PCS code, specific enough to report Medication Management for Substance Abuse Treatment, Bupropion on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in HZ87ZZZ mean?
HZ87ZZZ breaks down character by character: the 1st character H is the Section (Substance Abuse Treatment); the 2nd character Z is the Body System (Substance Abuse Treatment); the 3rd character 8 is the Type (Medication Management); the 4th character 7 is the Qualifier (Bupropion); the 5th character Z is the Qualifier (None); the 6th character Z is the Qualifier (None); the 7th character Z is the Qualifier (None).
What is the ICD-9-PCS equivalent of HZ87ZZZ?
Under the General Equivalence Mappings, Medication Management for Substance Abuse Treatment, Bupropion crosswalks to ICD-9-PCS 94.64. The mapping is approximate, so confirm it fits the documentation.
